Cara Therapeutics | CARA - Ebit





Ebit Veränderung Datum
Acadia Pharmaceuticals USD 37.84M 42.45M 2026-06
Alterity Therapeutics Limited AUD -8.07M 302.4K 2025-12
Cara Therapeutics USD -7.05M 1.11M 2026-03
Cassava Sciences USD -11.17M 2.38M 2026-03
Chugai Pharma JPY 160.86B 2.09B 2026-06
Cipla INR 8.88B 2.74B 2026-06
Clal Biotechnology ILS -5.44M 3.76M 2022-12
Compugen USD -9.02M 65.06M 2026-03
CSL USD 2.64B 116M 2025-12
Grifols EUR 320.55M 91.01M 2025-12
Halozyme Therapeutics USD -63.72M 1.95M 2026-06
J&J USD 7.48B 860M 2026-06
Neurocrine Biosciences USD 219.9M 5.3M 2026-06
Pacira USD 9.96M 5.33M 2026-06
Pfizer USD -180M 5.16B 2026-06
RedHill Biopharma USD 2.69M 47.97M 2023-06
Supernus Pharmaceuticals USD -21.04M 14.21M 2026-06
Vanda Pharmaceuticals USD -10.28M 721K 2024-12